Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2016 19:00 ET | Source: Theratechnologies Inc.

Theratechnologies annonce que la période de traitement des patients pour l'étude de phase III relative à l'ibalizumab est terminée

MONTRÉAL, QUÉBEC--(Marketwired - 24 oct. 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d'annoncer que son partenaire, TaiMed Biologics, Inc., l'a...
October 24, 2016 19:00 ET | Source: Theratechnologies Inc.

Theratechnologies Announces End of Patient Treatment for Phase III Ibalizumab Trial

MONTREAL, QUEBEC--(Marketwired - Oct. 24, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that it has been notified today by its partner, TaiMed...
October 04, 2016 07:00 ET | Source: Theratechnologies inc.

Theratechnologies annonce ses résultats financiers pour le troisième trimestre de 2016

MONTREAL, QUEBEC--(Marketwired - 4 oct. 2016) - Theratechnologies Inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd'hui ses résultats financiers pour le...
October 04, 2016 07:00 ET | Source: Theratechnologies inc.

Theratechnologies Announces Financial Results for Third Quarter of 2016

MONTREAL, QUEBEC--(Marketwired - Oct. 4, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced its financial results for the third quarter ended August 31, 2016. ...
September 28, 2016 09:56 ET | Source: Theratechnologies inc.

Theratechnologies va de l'avant avec le développement d'une nouvelle formulation en fiole unique d'EGRIFTA(MD) (tésamoréline pour injection)

MONTRÉAL, QUÉBEC--(Marketwired - 28 sept. 2016) - Theratechnologies inc. (Theratechnologies) (TSX:TH) a annoncé aujourd'hui qu'elle ira de l'avant avec le...
September 28, 2016 09:55 ET | Source: Theratechnologies Inc.

Theratechnologies to Move Forward With Development of New Single Vial Formulation for EGRIFTA(R) (Tesamorelin for Injection)

MONTREAL, QUEBEC--(Marketwired - Sept. 28, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it will move forward with the development of the F4 single vial...
September 27, 2016 10:08 ET | Source: Theratechnologies inc.

Theratechnologies annoncera ses résultats du troisième trimestre de 2016

MONTRÉAL, QUÉBEC--(Marketwired - 27 sept. 2016) - Theratechnologies Inc. (TSX:TH) (Theratechnologies) a annoncé aujourd'hui qu'elle dévoilera ses résultats...
September 27, 2016 10:08 ET | Source: Theratechnologies Inc.

Theratechnologies to Announce Financial Results for the Third Quarter of 2016

MONTREAL, QUEBEC--(Marketwired - Sept. 27, 2016) - Theratechnologies Inc. (TSX:TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended...
September 01, 2016 12:14 ET | Source: Theratechnologies inc.

Theratechnologies annonce une entente de commercialisation visant la tésamoréline en Espagne et au Portugal

MONTRÉAL, CANADA--(Marketwired - 1 sept. 2016) - Theratechnologies Inc. (TSX:TH) est heureuse d'annoncer qu'elle a conclu des ententes avec Praxis Pharmaceutical, S.A. et sa filiale,...
September 01, 2016 12:13 ET | Source: Theratechnologies Inc.

Theratechnologies Announces Commercialization Agreement for Tesamorelin in Spain and Portugal

MONTREAL, CANADA--(Marketwired - Sept. 1, 2016) - Theratechnologies Inc. (TSX:TH) is pleased to announce that it has concluded agreements with Praxis Pharmaceutical, S.A. and its...